Novel Measurement of the Neutron Magnetic Form Factor from A=3 Mirror Nuclei

The electromagnetic form factors of the proton and neutron encode information on the spatial structure of their charge and magnetization distributions. While measurements of the proton are relatively straightforward, the lack of a free neutron target makes measurements of the neutron's electromagnetic structure more challenging and more sensitive to experimental or model-dependent uncertainties. Various experiments have attempted to extract the neutron form factors from scattering from the neutron in deuterium, with different techniques providing different, and sometimes large, systematic uncertainties. We present results from a novel measurement of the neutron magnetic form factor using quasielastic scattering from the mirror nuclei ^{3}H and ^{3}He, where the nuclear effects are larger than for deuterium but expected to largely cancel in the cross-section ratios. We extracted values of the neutron magnetic form factor for low-to-modest momentum transfer, 0.6 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

S N Santiesteban University of New Hampshire, Durham, New Hampshire 03824, USA
S Li University of New Hampshire, Durham, New Hampshire 03824, USA Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
D Abrams University of Virginia, Charlottesville, Virginia 22904, USA
S Alsalmi Kent State University, Kent, Ohio 44240, USA King Saud University, Riyadh 11451, Kingdom of Saudi Arabia
D Androic University of Zagreb, Zagreb, Croatia
K Aniol California State University, Los Angeles, California 90032, USA
J Arrington Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA Argonne National Laboratory, Lemont, Illinois 60439, USA
T Averett William and Mary, Williamsburg, Virginia 23185, USA
C Ayerbe Gayoso William and Mary, Williamsburg, Virginia 23185, USA
J Bane University of Tennessee, Knoxville, Tennessee 37966, USA
S Barcus William and Mary, Williamsburg, Virginia 23185, USA
J Barrow University of Tennessee, Knoxville, Tennessee 37966, USA Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
A Beck Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
V Bellini INFN Sezione di Catania, Italy
H Bhatt Mississippi State University, Mississippi State, Mississippi 39762, USA
D Bhetuwal Mississippi State University, Mississippi State, Mississippi 39762, USA
D Biswas Hampton University, Hampton, Virginia 23669, USA
A Camsonne Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
J Castellanos Florida International University, Miami, Florida 33199, USA
J Chen William and Mary, Williamsburg, Virginia 23185, USA
J-P Chen Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
D Chrisman Michigan State University, East Lansing, Michigan 48824, USA
M E Christy Hampton University, Hampton, Virginia 23669, USA Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
C Clarke Stony Brook, State University of New York, New York 11794, USA
S Covrig Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
R Cruz-Torres Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
D Day University of Virginia, Charlottesville, Virginia 22904, USA
D Dutta Mississippi State University, Mississippi State, Mississippi 39762, USA
E Fuchey University of Connecticut, Storrs, Connecticut 06269, USA
C Gal University of Virginia, Charlottesville, Virginia 22904, USA
F Garibaldi INFN, Rome, Italy
T N Gautam Hampton University, Hampton, Virginia 23669, USA
T Gogami Tohoku University, Sendai, Japan
J Gomez Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
P Guèye Hampton University, Hampton, Virginia 23669, USA Michigan State University, East Lansing, Michigan 48824, USA
T J Hague Kent State University, Kent, Ohio 44240, USA
J O Hansen Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
F Hauenstein Old Dominion University, Norfolk, Virginia 23529, USA
W Henry Temple University, Philadelphia, Pennsylvania 19122, USA
D W Higinbotham Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
R J Holt Argonne National Laboratory, Lemont, Illinois 60439, USA
C Hyde Old Dominion University, Norfolk, Virginia 23529, USA
K Itabashi Tohoku University, Sendai, Japan
M Kaneta Tohoku University, Sendai, Japan
A Karki Mississippi State University, Mississippi State, Mississippi 39762, USA
A T Katramatou Kent State University, Kent, Ohio 44240, USA
C E Keppel Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
P M King Ohio University, Athens, Ohio 45701, USA
L Kurbany University of New Hampshire, Durham, New Hampshire 03824, USA
T Kutz Stony Brook, State University of New York, New York 11794, USA
N Lashley-Colthirst Hampton University, Hampton, Virginia 23669, USA
W B Li William and Mary, Williamsburg, Virginia 23185, USA
H Liu Columbia University, New York, New York 10027, USA
N Liyanage University of Virginia, Charlottesville, Virginia 22904, USA
E Long University of New Hampshire, Durham, New Hampshire 03824, USA
A Lovato Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA Computational Science Division, Argonne National Laboratory, Argonne, Illinois 60439, USA INFN-TIFPA Trento Institute for Fundamental Physics and Applications, 38123 Trento, Italy
J Mammei University of Manitoba, Winnipeg, MB R3T 2N2, Canada
P Markowitz Florida International University, Miami, Florida 33199, USA
R E McClellan Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
F Meddi INFN, Rome, Italy
D Meekins Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
R Michaels Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
M Mihovilovič Jožef Stefan Institute, 1000 Ljubljana, Slovenia Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, DE-55128 Mainz, Germany
A Moyer Christopher Newport University, Newport News, Virginia 23606, USA
S Nagao Tohoku University, Sendai, Japan
D Nguyen University of Virginia, Charlottesville, Virginia 22904, USA
M Nycz Kent State University, Kent, Ohio 44240, USA
M Olson Saint Norbert College, De Pere, Wisconsin 54115, USA
L Ou Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
V Owen William and Mary, Williamsburg, Virginia 23185, USA
C Palatchi University of Virginia, Charlottesville, Virginia 22904, USA
B Pandey Hampton University, Hampton, Virginia 23669, USA
A Papadopoulou Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
S Park Stony Brook, State University of New York, New York 11794, USA
T Petkovic University of Zagreb, Zagreb, Croatia
S Premathilake University of Virginia, Charlottesville, Virginia 22904, USA
V Punjabi Norfolk State University, Norfolk, Virginia 23529, USA
R D Ransome Rutgers University, New Brunswick, New Jersey 08854, USA
P E Reimer Argonne National Laboratory, Lemont, Illinois 60439, USA
J Reinhold Florida International University, Miami, Florida 33199, USA
S Riordan Argonne National Laboratory, Lemont, Illinois 60439, USA
N Rocco Theoretical Physics Department, Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
V M Rodriguez División de Ciencias y Tecnología, Universidad Ana G. Méndez, Recinto de Cupey, San Juan 00926, Puerto Rico
A Schmidt Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
B Schmookler Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
E P Segarra Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
A Shahinyan Yerevan Physics Institute, Yerevan, Armenia
S Širca Jožef Stefan Institute, 1000 Ljubljana, Slovenia Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia
K Slifer University of New Hampshire, Durham, New Hampshire 03824, USA
P Solvignon University of New Hampshire, Durham, New Hampshire 03824, USA
T Su Kent State University, Kent, Ohio 44240, USA
R Suleiman Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
L Tang Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
Y Tian Syracuse University, Syracuse, New York 13244, USA
W Tireman Northern Michigan University, Marquette, Michigan 49855, USA
F Tortorici INFN Sezione di Catania, Italy
Y Toyama Tohoku University, Sendai, Japan
K Uehara Tohoku University, Sendai, Japan
G M Urciuoli INFN, Rome, Italy
D Votaw Michigan State University, East Lansing, Michigan 48824, USA
J Williamson University of Glasgow, Glasgow, G12 8QQ Scotland, United Kingdom
B Wojtsekhowski Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
S Wood Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
Z H Ye Argonne National Laboratory, Lemont, Illinois 60439, USA Tsinghua University, Beijing, China
J Zhang University of Virginia, Charlottesville, Virginia 22904, USA
X Zheng University of Virginia, Charlottesville, Virginia 22904, USA

Collapse

Prenatal exposure to polycyclic aromatic hydrocarbons and cognition in early childhood

BACKGROUND

Epidemiological evidence for gestational polycyclic aromatic hydrocarbon (PAH) exposure and adverse child cognitive outcomes is mixed; little is known about critical windows of exposure.

OBJECTIVE

We investigated associations between prenatal PAH exposure and child cognition in a large, multi-site study.

METHODS

We included mother-child dyads from two pooled prospective pregnancy cohorts (CANDLE and TIDES, N = 1,223) in the ECHO-PATHWAYS Consortium. Seven urinary mono-hydroxylated PAH metabolites were measured in mid-pregnancy in both cohorts as well as early and late pregnancy in TIDES. Child intelligence quotient (IQ) was assessed between ages 4-6. Associations between individual PAH metabolites and IQ were estimated with multivariable linear regression. Interaction terms were used to examine effect modification by child sex and maternal obesity. We explored associations of PAH metabolite mixtures with IQ using weighted quantile sum regression. In TIDES, we averaged PAH metabolites over three periods of pregnancy and by pregnancy period to investigate associations between PAH metabolites and IQ.

RESULTS

In the combined sample, PAH metabolites were not associated with IQ after full adjustment, nor did we observe associations with PAH mixtures. Tests of effect modification were null except for the association between 2-hydroxynaphthalene and IQ, which was negative in males (βmales = -0.67 [95%CI:-1.47,0.13]) and positive in females (βfemales = 0.31 [95%CI:-0.52,1.13])(pinteraction = 0.04). In analyses across pregnancy (TIDES-only), inverse associations with IQ were observed for 2-hydroxyphenanthrene averaged across pregnancy (β = -1.28 [95%CI:-2.53,-0.03]) and in early pregnancy (β = -1.14 [95%CI:-2.00,-0.28]).

SIGNIFICANCE

In this multi-cohort analysis, we observed limited evidence of adverse associations of early pregnancy PAHs with child IQ. Analyses in the pooled cohorts were null. However, results also indicated that utilizing more than one exposure measures across pregnancy could improve the ability to detect associations by identifying sensitive windows and improving the reliability of exposure measurement. More research with multiple timepoints of PAH assessment is warranted.

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group

INTRODUCTION

Next-generation sequencing (NGS) diagnostics have shown clinical utility in predicting survival benefits in patients with certain cancer types who are undergoing targeted drug therapies. Currently, there are no guidelines or recommendations for the use of NGS in patients with metastatic cancer from an Asian perspective. In this article, we present the Asia-Pacific Oncology Drug Development Consortium (APODDC) recommendations for the clinical use of NGS in metastatic cancers.

METHODS

The APODDC set up a group of experts in the field of clinical cancer genomics to (i) understand the current NGS landscape for metastatic cancers in the Asia-Pacific (APAC) region; (ii) discuss key challenges in the adoption of NGS testing in clinical practice; and (iii) adapt/modify the European Society for Medical Oncology guidelines for local use. Nine cancer types [breast cancer (BC), gastric cancer (GC), nasopharyngeal cancer (NPC), ovarian cancer (OC), prostate cancer, lung cancer, and colorectal cancer (CRC) as well as cholangiocarcinoma and hepatocellular carcinoma (HCC)] were identified, and the applicability of NGS was evaluated in daily practice and/or clinical research. Asian ethnicity, accessibility of NGS testing, reimbursement, and socioeconomic and local practice characteristics were taken into consideration.

RESULTS

The APODDC recommends NGS testing in metastatic non-small-cell lung cancer (NSCLC). Routine NGS testing is not recommended in metastatic BC, GC, and NPC as well as cholangiocarcinoma and HCC. The group suggested that patients with epithelial OC may be offered germline and/or somatic genetic testing for BReast CAncer gene 1 (BRCA1), BRCA2, and other OC susceptibility genes. Access to poly (ADP-ribose) polymerase inhibitors is required for NGS to be of clinical utility in prostate cancer. Allele-specific PCR or a small-panel multiplex-gene NGS was suggested to identify key alterations in CRC.

CONCLUSION

This document offers practical guidance on the clinical utility of NGS in specific cancer indications from an Asian perspective.

Prenatal phthalate exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE cohort

CONTEXT

Phthalates may disrupt maternal-fetal-placental endocrine pathways, affecting pregnancy outcomes and child development. Placental corticotropin releasing hormone (pCRH) is critical for healthy pregnancy and child development, but understudied as a target of endocrine disruption.

OBJECTIVE

To examine phthalate metabolite concentrations (as mixtures and individually) in relation to pCRH.

DESIGN

Secondary data analysis from a prospective cohort study.

SETTING

Prenatal clinics in Tennessee, USA.

PATIENTS

1018 pregnant women (61.4% non-Hispanic Black, 32% non-Hispanic White, 6.6% other) participated in the CANDLE study and provided data. Inclusion criteria included: low-medical-risk singleton pregnancy, age 16-40, and gestational weeks 16-29.

INTERVENTION

None.

MAIN OUTCOME MEASURES

Plasma pCRH at two visits (mean gestational ages 23.0 and 31.8 weeks) and change in pCRH between visits (ΔpCRH).

RESULTS

In weighted quantile sums (WQS) regression models, phthalate mixtures were associated with higher pCRH at Visit 1 (β = 0.07, 95 %CI: 0.02, 0.11) but lower pCRH at Visit 2 (β = -0.08, 95 %CI: -0.14, -0.02). In stratified analyses, among women with gestational diabetes (n = 59), phthalate mixtures were associated with lower pCRH at Visit 1 (β = -0.17, 95 %CI: -0.35, 0.0006) and Visit 2 (β = -0.35, 95 %CI: -0.50, -0.19), as well as greater ΔpCRH (β = 0.16, 95 %CI: 0.07, 0.25). Among women with gestational hypertension (n = 102), phthalate mixtures were associated with higher pCRH at Visit 1 (β = 0.20, 95 %CI: 0.03, 0.36) and Visit 2 (β = 0.42; 95 %CI: 0.19, 0.64) and lower ΔpCRH (β = -0.17, 95 %CI: -0.29, -0.06). Significant interactions between individual phthalate metabolites and pregnancy complications were observed.

CONCLUSIONS

Phthalates may impact placental CRH secretion, with differing effects across pregnancy. Differences in results between women with and without gestational diabetes and gestational hypertension suggest a need for further research examining whether women with pregnancy complications may be more vulnerable to endocrine-disrupting effects of phthalates.

Nitrated Polycyclic Aromatic Hydrocarbons and Arachidonic Acid Metabolisms Relevant to Cardiovascular Pathophysiology: Findings from a Panel Study in Healthy Adults

Concerns on nitrated polycyclic aromatic hydrocarbons (nitro-PAHs) in the environment have mainly arisen from their mutagenic and carcinogenic effects. The objective of this study is to investigate whether nitro-PAH exposures are associated with biomarkers of cardiovascular pathophysiology. In a panel study design, urines and blood samples were collected up to four times with a 2-week interval from 89 healthy adults. We measured 1-naphthylamine, 2-naphthylamine, 9-aminophenanthrene, 2-aminofluorene, and 1-aminopyrene as biomarkers of nitro-PAH exposures. We measured three urinary metabolites of arachidonic acid (AA) including 20-hydroxyeicosatetraenoic acid (20-HETE) from the cytochrome P450 (CYP) pathway, 8-isoprostane from the nonenzymatic pathway, and 11-dehydro-thromboxane B2 (11-dhTXB₂) from the cyclooxygenase (COX) pathway. Urinary malondialdehyde, 8-hydroxy-2'-deoxyguanosine (8-OHdG), and 6-sulfatoxymelatonin (aMT6s) were measured to reflect systemic oxidative stress. Plasma concentrations of the soluble P-selectin and von Willebrand factor (vWF) were measured as biomarkers of platelet activation and endothelial dysfunction. We found that increased urinary concentrations of amino-PAHs were significantly associated with increased 20-HETE, 11-dhTXB₂, and 8-OHdG and with decreased 8-isoprostane and aMT6s. Increased amino-PAHs were positively associated with P-selectin and vWF, respectively. These results suggest that exposure to nitro-PAHs increases systemic oxidative stress and alters AA metabolism toward CYP and COX pathways, leading to an increased cardiovascular disease risk.

Ruling out Color Transparency in Quasielastic ^{12}C(e,e^{'}p) up to Q^{2} of 14.2 (GeV/c)^{2}

Quasielastic ^{12}C(e,e^{'}p) scattering was measured at spacelike 4-momentum transfer squared Q^{2}=8, 9.4, 11.4, and 14.2  (GeV/c)^{2}, the highest ever achieved to date. Nuclear transparency for this reaction was extracted by comparing the measured yield to that expected from a plane-wave impulse approximation calculation without any final state interactions. The measured transparency was consistent with no Q^{2} dependence, up to proton momenta of 8.5  GeV/c, ruling out the quantum chromodynamics effect of color transparency at the measured Q^{2} scales in exclusive (e,e^{'}p) reactions. These results impose strict constraints on models of color transparency for protons.

Probing the Deuteron at Very Large Internal Momenta

We measure ^{2}H(e,e^{'}p)n cross sections at 4-momentum transfers of Q^{2}=4.5±0.5  (GeV/c)^{2} over a range of neutron recoil momenta p_{r}, reaching up to ∼1.0  GeV/c. We obtain data at fixed neutron recoil angles θ_{nq}=35°, 45°, and 75° with respect to the 3-momentum transfer q[over →]. The new data agree well with previous data, which reached p_{r}∼500  MeV/c. At θ_{nq}=35° and 45°, final state interactions, meson exchange currents, and isobar currents are suppressed and the plane wave impulse approximation provides the dominant cross section contribution. We compare the new data to recent theoretical calculations, where we observe a significant discrepancy for recoil momenta p_{r}>700  MeV/c.

Endogenous melatonin mediation of systemic inflammatory responses to ozone exposure in healthy adults

BACKGROUND/AIM

Melatonin is a free radical scavenger and an anti-inflammatory biomolecule. Air pollution exposure has been associated with increased inflammatory responses. We hypothesize that endogenous melatonin plays a role in inflammatory responses to air pollution exposure.

METHODS

We tested this hypothesis in a cohort of 53 healthy adults (22-52 years old, 16 women), none of whom were on melatonin supplementation. Early morning urine and fasting blood were collected from each participant longitudinally up to three times. We analyzed urinary 6-sulfatoxymelatonin (aMT6s), as a surrogate of circulating melatonin, and pro- and anti-inflammatory cytokines in the plasma samples. Indoor and outdoor air pollutants were measured and combined with participants' time-activity patterns to calculate personal exposure to O₃, PM_2.5, NO₂, and SO₂ averaged over 12-hour, 24-hour, 1-week, and 2-week periods prior to biospecimen collection, respectively. Linear mixed-effects models were used to examine the relationships among urinary aMT6s, personal pollutant exposure, and plasma cytokines. A mediation analysis was conducted to examine the role of aMT6s in the relationships between pollutant exposures and inflammatory cytokines.

RESULTS

One interquartile range (4.2 ppb) increase in 2-week O₃ exposure was associated with a -26.2% (95% CI: -43.9% to -2.8%) decrease in aMT6s. Within the range of endogenous aMT6s concentrations (0.5-53.0 ng/ng creatinine) across the participants, increased aMT6s was associated with decreased pro-inflammatory cytokines including IL-1β, IL-8, IL-17A, IFN-γ, and TNF-α. These cytokines were significantly and positively associated with 2-week average O₃ exposure. Furthermore, 7.4% to 17.4% of the O₃-cytokine associations were mediated by aMT6s. We did not find similar effects for the other pollutants.

CONCLUSIONS

Pro-inflammatory responses to O₃ exposure in the preceding 2 weeks partly resulted from the depletion of endogenous melatonin by O₃.

Associations of ozone exposure with urinary metabolites of arachidonic acid

BACKGROUND

Ozone (O₃) exposure has been associated with biomarkers of platelet activation and oxidative stress. The metabolism of arachidonic acid (AA) plays an important role in platelet activation and oxidative stress. However, AA metabolic pathways have not been examined in relation to O₃ and other air pollutants.

METHODS

Early morning urine and fasting blood were longitudinally collected up to four times from 89 healthy adults (22-52 years old, 25 women) in Changsha City, China. We measured three urinary AA metabolites, namely 11-dehydro-Thromboxane B2 (11-dhTXB₂) produced from the arachidonic cyclooxygenase pathway, 20-hydroxyeicosatetraenoic acid (20-HETE) from the CYPs pathway, and 8-isoprostane from the non-enzymatic pathway. Urinary malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) were measured as indicators of oxidative damage to lipids and DNA, respectively. We measured soluble P-selectin (sCD62p) concentrations in plasma as an indicator of platelet activation. Indoor and outdoor air pollutants were measured and combined with participants' time-activity pattern to calculate personal exposure to O₃, PM_2.5, NO₂, and SO₂ averaged over 12-hour, 24-hour, 1-week, and 2-week periods prior to biospecimen collection, respectively. Linear mixed-effects models were used to examine the relationships of AA metabolites with air pollutant exposures, plasma sCD62p, and urinary MDA & 8-OHdG.

RESULTS

We found that a 10% increase in 12 h and 24 h O₃ exposure were associated with increases in urinary11-dhTXB₂ by 1.4% (95%, 0.1% to 2.6%) and 1.3% (0.05% to 2.5%), respectively. These associations remained robust after adjusting for co-pollutant exposures. No significant associations were observed between 11-dhTXB₂ and other pollutants or between O₃ exposures and other AA metabolites. All the three AA metabolites were significantly and positively associated with urinary MDA and 8-OHdG, whereas only urinary 11-dhTXB₂ was significantly and positively associated with plasma sCD62p.

CONCLUSIONS

A metabolite of AA from the cyclooxygenase pathway was positively associated with short-term O₃ exposure, and with a plasma marker of platelet activation and two urinary markers of oxidative stress. The results suggest that O₃ exposure may contribute to increased platelet activation and oxidative damages via altering the metabolism of AA.

Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck

BACKGROUND

Deregulation of the PI3K signalling pathway is frequent in squamous cell carcinoma of the head and neck (SCCHN) and may be implicated in radioresistance. We report on the results from a phase I 3 + 3 dose escalation study of alpelisib, a class I α-specific PI3K inhibitor in combination with concurrent cisplatin-based chemoradiation (CRT) in patients with locoregionally advanced SCCHN (LA-SCCHN).

METHODS

Eligible patients had previously untreated LA-SCCHN and were candidates for CRT. The primary objective was to evaluate safety and determine the recommended phase II dose (RP2D). Alpelisib was given orally once daily at two dose levels: 200 mg and 250 mg. CRT consisted of cisplatin 100 mg/m² IV every three weeks and standard fractionation radiotherapy (IMRT) 70 Gy in 35 fractions.

RESULTS

Nine patients were enrolled (six alpelisib 200 mg, three 250 mg). Oropharynx was the primary site in all patients (seven p16-positive; five T1-2N2M0, four T3-4N2-3M0 [AJCC 7th edition]). All patients completed CRT within seven weeks. Grade 3 alpelisib-related toxicities occurred in four patients. No dose-limiting toxicity (DLT) was observed at 200 mg among three DLT-evaluable patients. Two of two DLT-evaluable patients treated at 250 mg experienced DLTs (inability to complete ≥75% alpelisib secondary to radiation dermatitis and febrile neutropenia). Thus, RP2D was declared at 200 mg. After median follow-up of 39.7 months, two patients developed pulmonary metastases despite locoregional control. Three-year overall survival was 77.8% (95% CI 36.5%-93.9%).

CONCLUSION

Alpelisib at 200 mg has a manageable safety profile in combination with cisplatin-based CRT in LA-SCCHN.

A versatile Johansson-type tender x-ray emission spectrometer

We present a high energy resolution x-ray spectrometer for the tender x-ray regime (1.6-5.0 keV) that was designed and operated at Stanford Synchrotron Radiation Lightsource. The instrument is developed on a Rowland geometry (500 mm of radius) using cylindrically bent Johansson analyzers and a position sensitive detector. By placing the sample inside the Rowland circle, the spectrometer operates in an energy-dispersive mode with a subnatural line-width energy resolution (∼0.32 eV at 2400 eV), even when an extended incident x-ray beam is used across a wide range of diffraction angles (∼30° to 65°). The spectrometer is enclosed in a vacuum chamber, and a sample chamber with independent ambient conditions is introduced to enable a versatile and fast-access sample environment (e.g., solid/gas/liquid samples, in situ cells, and radioactive materials). The design, capabilities, and performance are presented and discussed.

Revealing Color Forces with Transverse Polarized Electron Scattering

The Spin Asymmetries of the Nucleon Experiment measured two double spin asymmetries using a polarized proton target and polarized electron beam at two beam energies, 4.7 and 5.9 GeV. A large-acceptance open-configuration detector package identified scattered electrons at 40° and covered a wide range in Bjorken x (0.3<x<0.8). Proportional to an average color Lorentz force, the twist-3 matrix element, d[over ˜]_{2}^{p}, was extracted from the measured asymmetries at Q^{2} values ranging from 2.0 to 6.0  GeV^{2}. The data display the opposite sign compared to most quark models, including the lattice QCD result, and an unexpected scale dependence. Furthermore, when combined with the neutron data in the same Q^{2} range the results suggest a flavor independent average color Lorentz force.

Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials

BACKGROUND

Immunotherapy (IO) agents can cause late-onset immune-related adverse events (irAEs). In phase I trials, observation for dose-limiting toxicities (DLTs) is typically limited to the first cycle. The incidence of delayed-onset DLTs and their potential impact on dose determination have not been fully elucidated.

PATIENTS AND METHODS

Consecutive patients enrolled in early phase IO trials at Princess Margaret Cancer Centre between August 2012 and September 2016 were retrospectively reviewed, applying trial-specific definitions for DLTs. A clinically significant AE (csAE) was defined as a treatment-related adverse event requiring corticosteroids, hormone replacement, IO delay or discontinuation.

RESULTS

A total of 352 consecutive trial enrolments in 21 early phase clinical trials were included. Two-hundred seventy-eight patients (79%) received monotherapy and 74 (21%) received combination IO. Two hundred sixty (74%) patients experienced irAEs. There were two protocol-defined DLTs. Twenty (5.7%) patients had 24 csAEs qualifying as DLTs except for occurrence after the protocol-specified DLT period. One-hundred and six (10%) of irAEs were csAEs, including endocrine (26%), respiratory (14%), gastrointestinal (11%), general (10%), dermatological (8%), hepatic (8%), musculoskeletal (6%), pancreatic (6%), haematological, metabolic, neurological, cardiac (each 2%), infective and ocular (each 1%) events. The highest risk of first-onset csAE was during the first 4 weeks compared with the period from 4 weeks to end of treatment (odds ratio 3.13, 95% confidence interval 1.95-5.02). The median time to first onset csAE was significantly shorter with combination than monotherapy IO (32 vs. 146 days, P < 0.001).

CONCLUSIONS

In our series of early phase IO trials, the risk of csAE was highest during the initial 4 weeks on IO treatment, supporting the use of the conventional DLT period for dose escalation decision. However, there were 24 clinically significant late-onset DLTs in 5.7% of patients. Combination IO was associated with greater risk of and also earlier onset for csAE, which may need to be considered for early phase trial design.

Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review

BACKGROUND

Transcutaneous Vagus Nerve stimulation (tVNS) may be an alternative to surgically implanted VNS for epilepsy and other diseases. However, its safety and tolerability profile is unclear.

OBJECTIVE

We performed a systematic review of treatment harms from tVNS in humans.

METHODS

A systematic published and grey literature search was carried out to identify studies which deployed tVNS in human subjects. Study authors were contacted for safety/tolerability data if these were not available in the publication. Databases were searched from 1966 to May 2017. We noted study type, population, stimulation parameters, type and prevalence of side effects and/or serious adverse events (SAE). We also noted whether side effects/SAE were considered to be related to the tVNS and the proportion of participants dropping out of studies due to side effects.

RESULTS

51 studies were included comprising a total of 1322 human subjects receiving tVNS. The most common side effects were: local skin irritation from electrode placement (240 participants, 18.2%), headache (47, 3.6%) and nasopharyngitis (23, 1.7%). Whilst heterogeneity in overall side effect event rates between studies was not accounted for by the frequency (Hz) or pulse width (ms) of stimulation, a minority (35 participants (2.6%)) dropped out of studies due to side effects. Overall, 30 SAE occurred but only 3 were assessed by the relevant researchers to be possibly caused by tVNS.

CONCLUSION

tVNS is safe and well tolerated at the doses tested in research studies to date.

Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

Background

Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its ligand (PD-L1) produce unique toxicity profiles. The objective of this review was to identify patterns and incidence of immune-related adverse events (irAE) based on tumour type and ICI class.

Methods

Medline, EMBASE and COCHRANE databases were searched to identify prospective monotherapy trials of ICIs from 2003 to November 2015. Paired reviewers selected studies for inclusion and extracted data. Odds ratio (OR), χ2 tests and multivariable regression models were used to analyse for effect size and associations.

Results

We identified 48 trials (6938 patients), including 26 CTLA-4, 17 PD-1, 2 PD-L1 trials, and 3 studies tested both CTLA-4 and PD-1. Grade 3/4 irAE were more common with CTLA-4 mAbs compared with PD-1 (31% versus 10%). All grades colitis (OR 8.7, 95% CI 5.8-12.9), hypophysitis (OR 6.5, 95% CI 3.0-14.3) and rash (OR 2.0, 95% CI 1.8-2.3) were more frequent with CTLA-4 mAbs; whereas pneumonitis (OR 6.4, 95% CI 3.2-12.7), hypothyroidism (OR 4.3, 95% CI 2.9-6.3), arthralgia (OR 3.5, 95% CI 2.6-4.8) and vitiligo (OR 3.5, 95% CI 2.3-5.3) were more common with PD-1 mAbs. Comparison of irAE from the three most studied tumour types in PD-1 mAbs trials [melanoma (n = 2048), non-small-cell lung cancer (n = 1030) and renal cell carcinoma (n = 573)] showed melanoma patients had a higher frequency of gastrointestinal and skin irAE and lower frequency of pneumonitis.

Discussion

CTLA-4 and PD-1 mAbs have distinct irAE profiles. Different immune microenvironments may drive histology-specific irAE patterns. Other tumour-dependent irAE profiles may be identified as data emerge from ICI trials.

Ozone, Electrostatic Precipitators, and Particle Number Concentrations: Correlations Observed in a Real Office during Working Hours

This study investigates the impacts of outdoor and indoor ozone concentrations, ESP operation and occupancy on particle number concentrations within a modern office in Changsha, China. The office's one-pass air handling system contains a mini-bag filter (MERV 12) followed by an electrostatic precipitator (ESP) and high efficiency particulate air (HEPA) filter. Over a five-week period the system was operated either without the ESP (Stage 1, first-third week) or with the ESP (Stage 2, fourth and fifth week). Ozone and particle number concentrations were measured on working days. During both stages, indoor ozone and particle number concentrations tracked the outdoor ozone concentration. When operating, the ESP produced approximately 29 mg h(-1) of ozone, increasing supply air ozone by 15 ppb and steady-state indoor ozone by about 3 ppb. Occupancy tended to decrease indoor ozone and increase particle levels. During occupancy, indoor particle levels were low (∼2600 particle/cm(3)) when the supply air ozone level was less than 18 ppb. Above this threshold, the supply air ozone concentration and indoor particle number concentration were linearly related, and ESP operation increased the average indoor particle level by about 22 000 particles/cm(3). The implications for worker exposure to both ozone and particles are discussed.

Hypopharyngeal cancer: looking back, moving forward

Population-based datasets can provide observational insights into cancer incidence, [...]

Polarization Transfer in Wide-Angle Compton Scattering and Single-Pion Photoproduction from the Proton

Wide-angle exclusive Compton scattering and single-pion photoproduction from the proton have been investigated via measurement of the polarization transfer from a circularly polarized photon beam to the recoil proton. The wide-angle Compton scattering polarization transfer was analyzed at an incident photon energy of 3.7 GeV at a proton scattering angle of θ_{cm}^{p}=70°. The longitudinal transfer K_{LL}, measured to be 0.645±0.059±0.048, where the first error is statistical and the second is systematic, has the same sign as predicted for the reaction mechanism in which the photon interacts with a single quark carrying the spin of the proton. However, the observed value is ~3 times larger than predicted by the generalized-parton-distribution-based calculations, which indicates a significant unknown contribution to the scattering amplitude.

Probing the repulsive core of the nucleon-nucleon interaction via the (4)He(e,e'pN) triple-coincidence reaction

We studied simultaneously the (4)He(e,e'p), (4)He(e,e'pp), and (4)He(e,e'pn) reactions at Q(2)=2(GeV/c)(2) and x(B)>1, for an (e,e'p) missing-momentum range of 400 to 830  MeV/c. The knocked-out proton was detected in coincidence with a proton or neutron recoiling almost back to back to the missing momentum, leaving the residual A=2 system at low excitation energy. These data were used to identify two-nucleon short-range correlated pairs and to deduce their isospin structure as a function of missing momentum, in a region where the nucleon-nucleon (NN) force is expected to change from predominantly tensor to repulsive. The abundance of neutron-proton pairs is reduced as the nucleon momentum increases beyond ∼500  MeV/c. The extracted fraction of proton-proton pairs is small and almost independent of the missing momentum. Our data are compared with calculations of two-nucleon momentum distributions in (4)He and discussed in the context of probing the elusive repulsive component of the NN force.

High-order harmonic generation from a dual-gas, multi-jet array with individual gas jet control

We present a gas jet array for use in high-order harmonic generation experiments. Precise control of the pressure in each individual gas jet has allowed a thorough investigation into mechanisms contributing to the selective enhancement observed in the harmonic spectra produced by dual-gas, multi-jet arrays. Our results reveal that in our case, the dominant enhancement mechanism is the result of a compression of the harmonic-producing gas jet due to the presence of other gas jets in the array. The individual control of the gas jets in the array also provides a promising method for enhancing the harmonic yield by precise tailoring of the length and pressure gradient of the interaction region.

A High-Performance Corrosion-Resistant Iron-Based Amorphous Metal - The Effects of Composition, Structure and Environment on Corrosion Resistance

The passive film stability of several Fe-based amorphous metal formulations have been found to be comparable to that of high-performance Ni-based alloys, and superior to that of stainless steels, based on electrochemical measurements of the passive film breakdown potential and general corrosion rates. Chromium (Cr), molybdenum (Mo) and tungsten (W) provide corrosion resistance; boron (B) enables glass formation; and rare earths such as yttrium (Y) lower critical cooling rate (CCR). The high boron content of this particular amorphous metal also makes it an effective neutron absorber, and suitable for criticality control applications, as discussed in companion publications. Corrosion data for SAM2X5 (Fe49.7Cr17.7Mn1.9Mo7.4W1.6B15.2C3.8Si2.4) is discussed here.

Search for effects beyond the born approximation in polarization transfer observables in e(over→)p elastic scattering

Intensive theoretical and experimental efforts over the past decade have aimed at explaining the discrepancy between data for the proton electric to magnetic form factor ratio, G(E)/G(M), obtained separately from cross section and polarization transfer measurements. One possible explanation for this difference is a two-photon-exchange contribution. In an effort to search for effects beyond the one-photon-exchange or Born approximation, we report measurements of polarization transfer observables in the elastic H(e[over →],e(')p[over →]) reaction for three different beam energies at a Q(2)=2.5  GeV(2), spanning a wide range of the kinematic parameter ε. The ratio R, which equals μ(p)G(E)/G(M) in the Born approximation, is found to be independent of ε at the 1.5% level. The ε dependence of the longitudinal polarization transfer component P(ℓ) shows an enhancement of (2.3±0.6)% relative to the Born approximation at large ε.

Measurements of the electric form factor of the neutron up to Q2=3.4 GeV2 using the reaction 3He(e,e'n)pp

The electric form factor of the neutron was determined from studies of the reaction 3He(e,e'n)pp in quasielastic kinematics in Hall A at Jefferson Lab. Longitudinally polarized electrons were scattered off a polarized target in which the nuclear polarization was oriented perpendicular to the momentum transfer. The scattered electrons were detected in a magnetic spectrometer in coincidence with neutrons that were registered in a large-solid-angle detector. More than doubling the Q2 range over which it is known, we find G(E)(n)=0.0236±0.0017(stat)±0.0026(syst), 0.0208±0.0024±0.0019, and 0.0147±0.0020±0.0014 for Q(2)=1.72, 2.48, and 3.41 GeV2, respectively.

Probing quark-gluon interactions with transverse polarized scattering

We have extracted QCD matrix elements from our data on doubly polarized inelastic scattering of electrons on nuclei. We find the higher twist matrix element d˜2, which arises strictly from quark-gluon interactions, to be unambiguously nonzero. The data also reveal an isospin dependence of higher twist effects if we assume that the Burkhardt-Cottingham sum rule is valid. The fundamental Bjorken sum rule obtained from the a0 matrix element is satisfied at our low momentum transfer.

Recoil polarization measurements of the proton electromagnetic form factor ratio to Q2 = 8.5 GeV2

Among the most fundamental observables of nucleon structure, electromagnetic form factors are a crucial benchmark for modern calculations describing the strong interaction dynamics of the nucleon's quark constituents; indeed, recent proton data have attracted intense theoretical interest. In this Letter, we report new measurements of the proton electromagnetic form factor ratio using the recoil polarization method, at momentum transfers Q2=5.2, 6.7, and 8.5  GeV2. By extending the range of Q2 for which G(E)(p) is accurately determined by more than 50%, these measurements will provide significant constraints on models of nucleon structure in the nonperturbative regime.

MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation

3,4-methylenedioxymethamphetamine (MDMA) causes long-term serotonin depletion and reduced serotonin transporter (SERT) function in humans and in animal models. Using quantitative Western blotting and real-time PCR, we have shown that total SERT protein in the striatum and nucleus accumbens and mRNA levels in the dorsal raphe nucleus were not significantly changed following MDMA exposure in rats (4 x 2 h i.p. injections, 10 mg/kg each). In mouse neuroblastoma (N(2)A) cells transiently expressing green fluorescent protein-tagged human SERT (GFP-hSERT), we have shown redistribution of SERT from the cell surface to intracellular vesicles on exposure to MDMA using cell surface biotinylation, total internal reflection fluorescence microscopy (TIRFM) and live-cell confocal microscopy. To investigate the mechanism responsible for SERT redistribution, we used specific antibodies to phospho-p38-mitogen activated protein kinase (p38 MAPK), a known signalling pathway involved in SERT membrane expression. We found that p38 MAPK activation was not involved in the MDMA-induced redistribution of SERT from the cell-surface to the cell interior. A loss of SERT from the cell surface on acute exposure to MDMA may contribute to the decreased SERT function seen in rats exposed to MDMA.

New measurements of the European Muon Collaboration effect in very light nuclei

New Jefferson Lab data are presented on the nuclear dependence of the inclusive cross section from (2)H, (3)He, (4)He, (9)Be and (12)C for 0.3 < x < 0.9, Q(2) approximately 3-6 GeV(2). These data represent the first measurement of the EMC effect for (3)He at large x and a significant improvement for (4)He. The data do not support previous A-dependent or density-dependent fits to the EMC effect and suggest that the nuclear dependence of the quark distributions may depend on the local nuclear environment.

Inactivation and elimination of human enteric viruses by Pacific oysters

AIMS

To investigate the comparative elimination of three different human enterically transmitted viruses [i.e. hepatitis A virus (HAV), norovirus (NoV) and poliovirus (PV)] and inactivation of HAV and PV by Pacific oysters.

METHODS AND RESULTS

New Zealand grown Pacific oysters (Crassostrea gigas) were allowed to bioaccumulate HAV, NoV and PV. Samples of oyster gut, faeces and pseudofaeces were then analysed by using real-time RT-PCR to determine the amount of viral RNA and cell culture methods to identify changes in the number of plaque forming units. The results suggest that the majority of the PV present in the oyster gut and oyster faeces is noninfectious, while in contrast, most of the HAV detected in the oyster gut are infectious. Depuration experiments identified a large drop in the count of PV in the gut over a 23-h cleansing period, whereas the levels of HAV and NoV did not significantly decrease.

CONCLUSIONS

Human enterically transmitted viruses are eliminated and inactivated at different rates by Pacific oysters.

SIGNIFICANCE AND IMPACT OF STUDY

The research presented in this article has implications for risk management techniques that are used to improve the removal of infectious human enteric viruses from bivalve molluscs.